Changes in hemoglobin A ( 1c ) ( HbA ( 1c ) ) level ( primary ) , proportions of patients with attained treatment targets ( HbA ( 1c ) < 7 % ; blood pressure < 130/80 mm Hg ; low-density lipoprotein cholesterol < 2.6 mmol/L [ to convert to milligrams per deciliter , divide by 0.0256 ] ) ( secondary ) , and other health outcomes at month 12 .